Silencing CBS significantly inhibits ovarian cancer cell proliferation, metastatic nodule formation and sensitizes them to cisplatin both in vitro and in pre-clinical orthotopic mouse models in vivo. This evidence concerns the gene CBS and ovarian carcinoma.